P
Piramal Pharma Ltd
NSE:PPLPHARMA
Piramal Pharma Ltd
NSE:PPLPHARMA
Price:
146.47
INR
0.34%
Market Closed
Market Cap:
₹193.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
IN |
|
E
|
Eonmetall Group Bhd
KLSE:EMETALL
|
MY |
|
B
|
Bestore Co Ltd
SSE:603719
|
CN |
|
S
|
Sanrhea Technical Textiles Ltd
BSE:514280
|
IN |
|
King's Flair International (Holdings) Ltd
HKEX:6822
|
HK |
|
S
|
Shandong Yulong Gold Co Ltd
SSE:601028
|
CN |
|
Baida Group Co Ltd
SSE:600865
|
CN |
|
Andersons Inc
NASDAQ:ANDE
|
US |
|
A
|
Awardit AB publ
STO:AWRD
|
SE |
|
CMIC Holdings Co Ltd
TSE:2309
|
JP |
|
voestalpine AG
XETRA:VAS
|
AT |
|
T
|
Total Telcom Inc
XTSX:TTZ
|
CA |
|
M
|
Mitrajaya Holdings Bhd
KLSE:MHB
|
MY |
|
X
|
Xinhu Zhongbao Co Ltd
SSE:600208
|
CN |
|
S
|
Shopify Inc
TSX:SHOP
|
CA |
|
KLDiscovery Inc
OTC:KLDI
|
US |
|
Rosseti Severo-Zapad PAO
MOEX:MRKZ
|
RU |
|
PRA Group Inc
NASDAQ:PRAA
|
US |
|
C
|
Colruyt Group NV
XBRU:COLR
|
BE |
|
Urban Edge Properties
NYSE:UE
|
US |
|
TNG Ltd
ASX:TNG
|
AU |
|
Hsin Yung Chien Co Ltd
TWSE:2114
|
TW |
|
Beijing Vastdata Technology Co Ltd
SSE:603138
|
CN |
|
Akeso Inc
HKEX:9926
|
CN |
Income Statement
Earnings Waterfall
Piramal Pharma Ltd
Piramal Pharma Ltd
Income Statement
Piramal Pharma Ltd
Piramal Pharma Ltd
Currency: INR
| Mar-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue |
70 816
N/A
|
41 222
-42%
|
81 712
+98%
|
64 621
-21%
|
87 038
+35%
|
89 495
+3%
|
91 512
+2%
|
91 338
0%
|
89 357
-2%
|
88 714
-1%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(29 111)
|
(15 149)
|
(31 956)
|
(23 639)
|
(31 604)
|
(32 911)
|
(34 988)
|
(32 513)
|
(31 574)
|
(31 378)
|
|
| Gross Profit |
41 704
N/A
|
26 073
-37%
|
49 756
+91%
|
40 982
-18%
|
55 434
+35%
|
56 584
+2%
|
56 524
0%
|
58 824
+4%
|
57 784
-2%
|
57 335
-1%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(30 196)
|
(12 820)
|
(34 250)
|
(26 640)
|
(38 971)
|
(45 365)
|
(48 488)
|
(53 645)
|
(54 539)
|
(55 670)
|
|
| Selling, General & Administrative |
(24 163)
|
(9 973)
|
(26 347)
|
(16 295)
|
(21 891)
|
(22 215)
|
(29 648)
|
(23 464)
|
(23 983)
|
(24 419)
|
|
| Research & Development |
(864)
|
0
|
(1 007)
|
0
|
0
|
0
|
(971)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(6 767)
|
(3 707)
|
(7 406)
|
(5 670)
|
(7 592)
|
(7 697)
|
(7 716)
|
(8 291)
|
(8 397)
|
(8 556)
|
|
| Other Operating Expenses |
1 598
|
860
|
509
|
(4 675)
|
(9 488)
|
(15 453)
|
(10 153)
|
(21 890)
|
(22 159)
|
(22 695)
|
|
| Operating Income |
11 509
N/A
|
13 253
+15%
|
15 506
+17%
|
14 342
-8%
|
16 463
+15%
|
11 219
-32%
|
8 036
-28%
|
5 180
-36%
|
3 244
-37%
|
1 665
-49%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
585
|
(1 884)
|
1 053
|
(2 787)
|
(3 691)
|
(3 634)
|
1 305
|
(3 317)
|
(3 089)
|
(3 017)
|
|
| Non-Reccuring Items |
(70)
|
(323)
|
(628)
|
0
|
(628)
|
0
|
(949)
|
207
|
207
|
(204)
|
|
| Gain/Loss on Disposition of Assets |
(5)
|
0
|
(5)
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
|
| Total Other Income |
(13 221)
|
(9 903)
|
(14 134)
|
(9 537)
|
(8 926)
|
(3 892)
|
(4 259)
|
1 737
|
1 782
|
2 093
|
|
| Pre-Tax Income |
(1 202)
N/A
|
1 143
N/A
|
1 793
+57%
|
2 018
+13%
|
3 219
+60%
|
3 693
+15%
|
4 146
+12%
|
3 807
-8%
|
2 144
-44%
|
537
-75%
|
|
| Net Income | |||||||||||
| Tax Provision |
(663)
|
(540)
|
(1 615)
|
(1 790)
|
(2 766)
|
(3 304)
|
(3 235)
|
(2 826)
|
(2 381)
|
(2 174)
|
|
| Income from Continuing Operations |
(1 865)
|
602
|
178
|
227
|
453
|
389
|
911
|
981
|
(237)
|
(1 636)
|
|
| Net Income (Common) |
(1 865)
N/A
|
602
N/A
|
178
-70%
|
227
+28%
|
453
+99%
|
389
-14%
|
911
+134%
|
981
+8%
|
(237)
N/A
|
(1 636)
-589%
|
|
| EPS (Diluted) |
-1.53
N/A
|
0.47
N/A
|
0.14
-70%
|
0.17
+21%
|
0.34
+100%
|
0.31
-9%
|
0.68
+119%
|
0.74
+9%
|
-0.2
N/A
|
-1.26
-530%
|
|
Switch to:
Switch to:
See Also
Discover More
